Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
national top stories
opioid
2
×
abbvie
acute myeloid leukemia
alkermes
allergan
american society of clinical oncology
applied therapeutics
biosimilars
boulder/denver blog main
boulder/denver top stories
breast cancer
buprenorphine
cancer
cariprazine
cell therapy
christopher heery
cincor pharma
cystic fibrosis
deals
detroit blog main
detroit top stories
diabetic cardiomyopathy
drug prices
drugs
duchenne muscular dystrophy
elevatebio
eli lilly
eqt partners
europe
europe blog main
europe top stories
federal trade commission
What
fda
2
×
ahead
alkermes
antipsychotic
asco
benefits
bio
branded
caveats
choices
commissioner
commonly
consumers
costly
counterweight
designed
drug
drugs
effect
elevatebio
favor
gain
generic
graft
medications
medicine
offer
panel
prescribed
psyche
rises
roundup
supposed
tenure
treatment
vote
weighs
weight
won
Language
unset
Current search:
opioid
×
fda
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
